Neurovirology Overview

Principles

Definition

Neurovirology is the interdisciplinary field of study focused on the interactions between viruses and the nervous system. This discipline investigates viral infections of the central and peripheral nervous systems, the mechanisms of viral pathogenesis in neurological tissues, and the host immune response, aiming to understand and develop treatments for viral neurological diseases.

Ontological type

Core Mechanisms

Viral Pathogens

Host Immune Response

Key developments

Key Figures

Neurotropism and Reservoirs era

Anthony S. Fauci [1] emerged as a central figure in neurovirology during 1968-1995, with affiliations at Harvard University [3] and the University of Washington [4] in this era. His key contribution in this era comes from the 1986 paper Detection of AIDS Virus in Macrophages in Brain Tissue from AIDS Patients with Encephalopathy [7], which established viral CNS reservoirs and macrophage involvement as core features of neuropathogenesis. Howard E. Gendelman [2] is another pivotal figure, with roles at Johns Hopkins University [5] and Washington University in St. Louis [6] during this era. Gendelman's work on the same 1986 study [7] helped illuminate CNS infection and viral reservoirs, reinforcing the brain as a distinct virological compartment and shaping diagnostic and therapeutic perspectives of the time.

Neuroimmune-Driven Pathology era

Fred H. Gage [1], associated with Stanford University [3] and Johns Hopkins University [4] during this era, helped shape the neuroimmune-driven pathology landscape. His key contribution, Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector [7], underscored how vector-mediated gene delivery could model CNS infection and host responses, enabling stable expression critical for studying immune-mediated neural injury. Luigi Naldini [2], associated with San Raffaele University of Rome [5] and Thomas Jefferson University [6] during this era, contributed to the development of efficient lentiviral gene transfer relevant to CNS applications. His work, as exemplified by the same lentiviral vector study [7], illuminated how stable gene delivery to neural tissue could illuminate immune interactions and demyelination processes, shaping later neuroimmune-targeted therapeutic approaches.

Barrier and Entry Biology era

John Q. Trojanowski [1], affiliated with Harvard University [3] and the University of California, San Francisco [4], embodies the era's emphasis on barrier biology and CNS entry. His key contribution, as shown in Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice [6], demonstrated prion-like α-synuclein transmission and its role in initiating Parkinson-like neurodegeneration, a finding that clarified how misfolded proteins may breach barriers and propagate within the CNS in this era. Virginia M.-Y. Lee [2] is linked to the University of California, San Francisco [4] and the University of Pennsylvania [5] in this era. Her key contribution, reflected in Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice [6], helped establish the prion-like spread mechanism of α-synuclein and underscored the relevance of CNS vulnerability and barrier-targeted surveillance in neurovirology.